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Abstract. Replacement of Mg (II), the natural activator of brain hexokinase (EC 2.7.1.1) by
paramagnetic Mn (II) without affecting the physiological properties of the enzyme, has
rendered brain hexokinase accessible to investigations by magnetic resonance methods. Based
on such studies, a site on the enzyme, where Mn (II) binds directly with high affinity has been
identified and characterized in detail. Use of β, γ-bidentate Cr (III) ATP as an exchange-inert
analogue for Mn (II) ATP has shown that Mn (II) binding directly to the enzyme has no
catalytic role but another Mn (II) ion binding simultaneously and independently to the enzyme
through the nucleotide bridge participates in enzyme function. However, using this direct
binding Mn (II) ion and a covalently bound spin label as paramagnetic probes a beginning has
been made in mapping the ligand binding sites of the enzyme. Ultra-violet difference
spectroscopy has revealed the presence of at least two glucose 6-phosphate locations on the
enzyme one of which presumably is the high affinity regulatory site modulated by substrate
glucose. Elution behaviour of the enzyme on a phosphocellulose column suggests that glucose
induces a specific phosphate site on the enzyme to which the phosphate bearing regulatory
ligands of the enzyme may bind.
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Introduction 
 
Bovine brain hexokinase (EC 2.7.1.1), an enzyme catalyzing the phosphorylation of
glucose, requires Mg (II) as an activating cation for its function. It is a key enzyme in the
control of energy metabolism in the brain and derives its regulatory properties
principally from the inhibitory action of its reaction product, glucose 6-phosphate
(Glc-6-P), deinhibitory action of substrate, ATP and effector, Pi. Inspite of voluminous
work using kinetic and thermodynamic methods to study the interaction of this enzyme
with its substrates and effectors, it is still unclear whether the regulatory action of these
ligands occurs at its active site or allosteric sites (Colowick, 1973; Purich et al., 1973).
The answer to this question and the related one of the mechanism of action of this
enzyme, lies in the determination of conformations of substrates, regulators and metal
ions interacting with this enzyme and their relative location on the enzyme surface.
 In recent years we have attempted to resolve these issues using a combination of
spectroscopic and chromatographic methods. We have been able to replace Mg (II) by
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paramagnetic Μn (II) as the activating cation without any deleterious effects on the
physiological properties of this enzyme (Jarori et al.,1981,1984). This substitution has
enabled us to use magnetic resonance methodology, especially relaxation and spin-
labelling techniques (Mildvan and Cohn, 1970; Mildvan and Gupta, 1978; Mildvan et
al., 1980; Dwek, 1973) to address ourselves to the problem of the disposition of the
various ligand binding sites on the enzyme. In this paper we summarize and review our
progress to date. 
 
 
Materials and methods 
 
Chemicals
 
Sources of chemicals used in this work have been mentioned elsewhere (Jarori et al.,
1981,1984). Preparation of β, γ-bidentate Cr (III) ATP has been described by Jarori
et al. (1984).
 
Preparation of hexokinase
 
Type 1 hexokinase was purified from bovine brain mitochondria (Redkar and Kenkare,
1972) with one modification. EDTA was omitted from the second DEAE-cellulose
chromatography. In some experiments, the enzyme was prepared by the procedure of
Swarup and Kenkare (1980). Methods for the assay of hexokinase activity and the
determination of protein concentration have been described previously (Redkar and
Kenkare, 1972). The specific activity of the enzyme used in these experiments varied
between 50–80 units per mg protein. A unit is defined as the amount of enzyme which
converts one µ mol of substrate into product in 1 min. at 30°C.
 
Magnetic resonance experiments
 
Spin-lattice relaxation times (T1) of solvent water protons were measured as reported
earlier (Jarori et al., 1981, 1984). Determination of free Mn (II) was carried out using
ESR by measuring the amplitude of the third line towards the high field (Jarori et al.,
1981). High resolution proton NMR spectra of glucose and Glc-6-P and the relaxation
rates of their protons were obtained using a WH-270 Brüker high resolution Fourier
Transform (FT) NMR spectrometer located at Bangalore, India, and AM-500 high
resolution FT NMR spectrometer located at the Tata Institute of Fundamental
Research, Bombay. Proton T1 of glucose and Glc-6-P were measured using the
inversion recovery method. Other experimental details and methods for the prep-
aration of enzyme samples for NMR experiments have been published (Jarori et al.,
1981, 1984). 
Spin-labelling of hexokinase using 3-(2-iodoacetamido)-2,2,5,5-tetramethyl-l-
pyrrolidinyloxyl was carried out as described by Jarori et al. (1984).
 
Analysis of NMR data
 
The interaction of the metal ion (Mn (II) in the present case) with brain hexokinase was
characterized in terms of the enhancement factor (ε*), as defined elsewhere (Jarori et al.,
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1981, 1984). Water PRR data obtained under different conditions of experiment were
used to calculate the binary enhancement εb and free and bound fractions of Mn(II)
(Jarori et al., 1981, 1984) as discussed in detail by Mildvan and Cohn (1963) and Dwek
(1973). 
Strategy for the determination of distance between a ligand nucleus and a
paramagnetic probe, such as enzyme bound metal ion or spin label has been discussed
by Mildvan and Gupta (1978) and by Mildvan et al. (1980) and will not be presented
here. The method essentially consists of determining the effect of the paramagnetic
probe on the spin-lattice relaxation rate of a ligand nucleus exchanging into the
enzyme-probe complex. The following equation was used to calculate distances
 
 
(1)
 
where r is the distance from the paramagnetic probe to the nucleus in the complex, C is
a constant with a value of 812 for Mn (II) ion-proton interaction (Mildvan et al., 1980),
f is the ratio of the concentrations of the enzyme-probe-ligand complex and of the total
ligand in solution, Tl p is the spin-lattice relaxation time of the ligand nucleus, τC is the
correlation time characterizing the dipole-dipole interaction between the electron and
proton spins, and ω1 and ωs are the nuclear and electron resonance frequencies
respectively. The validity of eq. (1) is based on the assumption that the outer sphere
contribution (1/TO.S.) is negligible and that the relaxation time T1 M is very much greater
than the life time (τΜ) of the enzyme-probe-ligand complex, where T1 M is the
relaxation time of the ligand nucleus in the enzyme-paramagnetic probe complex.
If the assumptions made in deriving equation (1) are justified, distance can be found
after the three unknown parameters of eq. (1) (τc’q and fT1p) are experimentally
measured. Conversely if r is known from other studies as in the case of Mn–H2O
distance, then q the number of water ligands exchanging into the first co-ordination
sphere of Mn (II) bound to the enzyme, can also be determined.
 
 
 
Ultra-violet difference spectroscopy 
 
Ultra-violet difference spectra were recorded on a Cary-17D spectrophotometer.
1·0 cm path length quartz cells were used. The baseline was recorded with both the cells
containing the same enzyme solution. The difference spectrum produced by interaction
of the ligand was recorded after the addition of saturating concentration of the ligand
to the sample cell and an equal volume of buffer to the reference cell. Resulting 0·5 %
increase in volume has been neglected. Recorded spectra were corrected for base line
deviations. All spectra were recorded at room temperature (21°C).
 
 
 
Phosphocellulose chromatography
 
For preparation of the phosphocellulose column, cellulose phosphate was washed
successively with ethanol, water, 0·1 Μ HCl, water, 0·1 Μ NaOH and water. It was
then equilibrated with the appropriate buffer.
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Results and discussion
 
Characterization of Mn (II) and nucleotide binding sites of brain hexokinase
 
The divalant cation Mg (II) is the natural activator of brain hexokinase. This cation
being colourless and diamagnetic is not suitable for spectroscopic investigations.
Substitution of Mg (II) by Mn(II) has enabled us to employ magnetic resonance
methods to study the mode of co-ordination of metal ion-nucleotide complex with this
enzyme (Jarori et al., 1981, 1984). Water PRE data has been used to evaluate
equilibrium constants and the number of binding sites with respect to enzyme–Mn (II)
interaction. Our conclusions have been reinforced by the use of ESR to monitor
formation of enzyme–Mn (II) complex. Hydration number of Mn (II) bound to the
enzyme has also been determined on the basis of PRE data although the theoretical
groundwork for the determination of the hydration number is a matter of controversy
(Koenig, 1978; Waysbort and Navon, 1978). The results of our water PRE and ESR
studies (Jarori et al., 1981, 1984) are summarized below:
(i) Replacement of Mg (II) reduces the specific activity of hexokinase by about 40 %.
However, this replacement has no effect on the affinity of ATP for the enzyme or on the
regulatory properties of the enzyme.
(ii) Enzyme has one tight binding site for Mn (II) with KD = 25 ± 4 µΜ at pH 8·0,
23°C. 
(iii) There are about 7–9 weak binding sites for Mn (II) on the enzyme with an
average KD = 1400 ± 440 µΜ. Most of these sites may be non-specific, but activating
and inhibitory sites with their dissociation constants in the millimolar range also lie in
this group of binding sites (Jarori et al., 1981)
(iv) Manganous ion in enzyme Mn (II) complex at tight binding site has character-
istic binary enhancement εb = 3·5 ± 0·4 at 9 MHz, pH 8·0, 23°C.
(v) The average characteristic binary enhancement for weak binding sites is εb = 2·3
± 0·5 at 9 MHz, pH 8·0, 23°C. 
(vi) The dissociation constant of Mn (II) at tight binding site is strongly temperature 
dependent. The KD decreases with increase in temperature from 5°–30° indicating that
the stability of this metal binding site is strongly dependent upon hydrophobic
interactions. 
(vii) The average number of fast exchanging water molecules from first co-ordination
sphere of Mn (II) bound at the tight binding site is 2 at 18°C and about 1 at 30°C. This
low hydration number suggests that this tight binding Mn (II) is linked to the enzyme
through multiple co-ordination bonds.
 
Though the activating and inhibitory sites for Mn (II) that we have kinetically
identified are presumably among the weakly interacting Mn (II) sites (see figure 1 of
Jarori et al., 1981), we did not characterize them further. This was because at the high
concentrations of Mn (II) required in such experiments, many non-specific sites would
interact with Mn (II) and complicate the analysis. Further experiments described here
were confined only to the study of tight binding Mn. (II) site.
Kinetic studies (Ning et al., 1969) have shown that MgATP2 – is the true substrate for
brain hexokinase. The interaction of nucleotides, ATP and ADP, with the
enzyme-Mn (II) binary complex, was studied using the water PRE method (figure 1).
 
Biophysical studies on brain hexokinase                                                        111
 
 
 
Figure 1. PRE titration of hexokinase with ATP(O) and ADP (●) in the presence of
Mn Cl2. Solutions contained 50 µM Mn Cl2, 5 mM 2-mercaptoethanol, 10 mM NEM
acetate, pH 8·0 and hexokinase as indicated.
 
 
When nucleotides ATP or ADP were added to the enzyme Mn (II) binary complex,
increased enhancements over that for the binary complex at a given enzyme
concentration were observed. As the concentration of the nucleotide is increased the
observed enhancement ε* increases. This initial increase in ε* can be attributed to the
formation of an enzyme-nucleotide-Mn (II) complex. The decrease in ε* encountered at
higher nucleotide concentrations is apparently the result of competition between the
free nucleotide and the metal nucleotide complex for the nucleotide site on the enzyme
(Jarori et al., 1984).
These results (figure 1) suggested the formation of a nucleotide bridged ternary
complex in which Mn (II) is bound to the enzyme through the nucleotide, a pattern
characteristic of many other kinases (Mildvan and Cohn, 1970; Buttlaire and Cohn,
1974; Jones et al., 1972). On the other hand, our PRE studies on the interaction
of Mn (II) with the enzyme in the absence of the nucleotide, provided evidence for a
high affinity site on the enzyme where Mn (II) is bound directly. It was not clear
whether in the presence of the nucleotide, the high affinity Mn (II) site gets converted to
the nucleotide–Mn (II) site or nucleotide–Mn (II) binds at a separate site. To choose
between these two possibilities, the enzyme was titrated with Mn (II) in the presence of
Cr (III) ATP. Under these conditions Mn (II) cannot displace Cr (III) from its complex
with ATP as Cr (III) ATP is exchange-inert. At various concentrations of en-
zyme, Mn (II) and Cr (III) ATP, free Mn (II) concentration was monitored using ESR.
The results showed good agreement between the measured concentrations of
free Mn (II) and those calculated on the basis of Mn (II) binding to hexokinase even
with Cr (III) ATP occupying the nucleotide binding site. Mn (II) thus binds to brain
hexokinase in the presence of Cr (III) ATP and the stoichiometry of metal ion
interaction with the enzyme in the presence of the nucleotide is therefore two (Jarori et
al., 1984). Further support to the idea of two metal ions binding to the enzyme in the
 
112 Kenkare et al. 
 
 
Figure 2. Quenching of ESR signal of spin-labelled hexokinase by Mn (II). Concentration
of spin-labelled hexokinase was 67·3 µΜ. (A), no Mn (II); (B), 50 µΜ Μn (II); (C), 100 µΜ
Μn (II). Instrument settings were: scan range, 100 G; time constant, 0·50 sec.; modulation
amplitude, 2·0 G; receiver gain, 3·2 × 104; microwave power, 12 mW; field setting 3,390 G; scan
time, 8 min.; modulation frequency, 100KHz; Microwave frequency, 9·506 GHz, temperature
22°C. 
 
 
presence of the nucleotide comes from the competitive displacement of ATP-Mn (II)
from the enzyme by Glc-6-P resulting in the formation of enzyme-Mn (II)–Glc-6-P
complex (Jarori et al., 1984). That these two Mn (II) binding sites are distinctly located
on the enzyme is shown by our studies on spin-labelled hexokinase. It was found
that Mn (II) bound to the enzyme quenches the ESR signal of the covalently linked
nitroxyl radical (figure 2). However binding of ATP-Mn (II) to the enzyme does not
have any appreciable effect on the intensity of the ESR signal of the spin-labelled
enzyme (Jarori et al., 1984).
Since the divalent cation has an obligatory function in the hexokinase reaction, an
obvious question that arose was which one of these two metal ions fulfilled that role.
This question was probed using Cr (III) ATP as a phosphoryl donor in the presence of
14C-glucose (Jarori et al., 1984), using the method of Dunaway-Mariano and Cleland
(1980). The amount of product formed showed that brain hexokinase underwent
approximately a single turnover when Cr (III) ATP is used as the substrate (table 1). A
single turnover results since in the catalytic transfer of γ-phosphoryl group of
Cr (III) ATP to the 6-hydroxyl group of 14C-glucose, complete transfer does not take
place as Cr (III) ATP is an exchange-inert compound. The product obtained (Cr (III)
ATP–14C-Glc-6-P) which structurally resembles a transition-state analogue is released
very slowly from the enzyme. Addition of 500 µΜ Mn (II) has no effect on the reaction
although it binds at the tight-binding site of hexokinase. Thus it is evident from this
experiment, that of the two metal ions interacting with the enzyme in the presence of the
nucleotide, it is the one co-ordinated to it via the nucleotide that participates in
catalysis. The role of the second Mn (II) ion binding directly to the enzyme is not clear
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Table 1. Assay of substrate activity of Cr (III) ATP in the presence and absence of Mn (II).
 
1·0 ml reaction mixture contained 1 mM Cr (III) ATP, 1 mM 14C-u-glucose, 5 mM 2-mercaptoethanol,
100 mM NEM acetate buffer pH 6·5 in addition to the hexokinase and Mn (II) as indicated in the table.
 
 
to us so  far. Meanwhile this Mn (II) at  the tight-binding site is being used as a
paramagnetic reference point in the mapping of ligand binding sites on the enzyme
surface.
 
Tight-binding Mn (II) as a paramagnetic probe to study enzyme-sugar interactions
 
In the absence of the metal ion, brain hexokinase has no effect on the line widths of α
and β anomeric proton resonances of glucose. Conversely, in the absence of the enzyme,
Mn (II) has no effect on the line width. The Mn (II)–hexokinase complex however
broadens the C–(l) proton resonances of both α and β anomers. This unequivocally
establishes that bovine brain hexokinase does not exhibit any specificity for binding of
glucose anomers (Jarori et al., 1981). Glc-6-P, which is a product as well as an inhibitor
of hexokinase reaction also showed considerable broadening of the C–(l) proton
resonance of α and β anomers upon binding to the enzyme, though in this case Mn (II)
had no effect (Jarori et al., 1981). This lack of anomeric specificity for the binding of
glucose and Glc-6-P to the enzyme as revealed by magnetic resonance techniques is in
agreement with the observations made earlier by others (Sols and Crane, 1954; Salas et
al., 1965; Rose et al., 1974).
Interaction of glucose with enzyme-Mn (II) complex results in line broadening of
anomeric proton resonances of glucose due to paramagentic effect of Mn (II) on spin-
spin relaxation time (T2) of bound glucose which is in exchange with free glucose
molecules. The Swift and Connick (1962) equation was used to work out the spin-
spin relaxation rate (1/T2M) of glucose anomeric protons in the bound form. Under
conditions of fast exchange (T2M  τM), 1/T2M sets the lower limit for the rate of
dissociation of glucose from the enzyme which was found to be 1330 ± 170 s–1. The
kinetic data shows that the rate of the reverse reaction, i.e. the formation of glucose and
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ATP from Glc-6-P and ADP, is much slower than the rate of release of glucose (1330
± 170 s –1) from the enzyme. Thus the release of glucose from the enzyme is not the rate
limiting step in the reverse reaction. Interestingly, in yeast hexokinase, the release of
glucose from the enzyme in the reverse reaction is rate limiting (Rose et al., 1974).
 
 
Tight-binding Mn (II) site as a paramagnetic reference point for mapping of ligand
binding sites 
 
Precise location of various regulatory sites of brain hexokinase has become essential for
resolving controversies regarding the molecular mechanism of its control. Thus the
regulatory function of Glc-6-P, a product inhibitor of the enzyme, is variously
described as occurring at an allosteric site (Lazo et al., 1980) or at its active site (Solheim
and Fromm, 1981). The sites where ATP and inorganic phosphate bind to reverse the
inhibitory action of Glc-6-P is also not known. Results of kinetic studies carried out to
settle these issues (Colowick, 1973; Purich et al., 1973) have not been conclusive. Our
approach to the solution of these problems is to employ NMR relaxation methods
(Mildvan and Cohn, 1970; Mildvan and Gupta, 1978; Mildvan et al., 1980) and spin
labelling methods (Mildvan and Weiner, 1969; Jones et al., 1973; Cunningham et al.,
1981) to precisely locate the various ligand binding sites of the enzyme using the tightly
bound Mn (II) and the covalently linked spin label as paramagnetic reference points.
For unequivocal mapping of these sites it is necessary to have more paramagnetic
centres such as Cr (III) ATP and covalently or non-covalently attached spin labels.
As described earlier, measurement of the paramagnetic effect of a probe, in this case
Mn (II), on relaxation rates can under certain conditions provide information about the
physical distance between the probe and the relaxing nucleus. As shown in the
preceding section, addition of glucose to Mn (II)–hexokinase complex broadens the
C–(l) proton resonance of α as well as the β anomer, (H α1 and H β1  resonances) resulting
from the electron-nuclear dipolar interaction between the paramagnetic metal ion and
the C–(l) proton of the sugar. This result showed that in enzyme-Mn (II)–glucose
complex, Mn (II) is close enough to glucose to cause paramagnetic effects on relaxation
rates of glucose protons. The assignment of all the proton resonances in D–glucose
NMR spectrum is known (Koch and Perlin, 1970). The H α1 H β1  and H β2  (i.e. C–(2)
proton of β-anomer) resonances of D-glucose are well resolved in the glucose proton
spectra at 270 and 500 MHz. Spin-lattice relaxation rate measurements have been made
at 270 and 500 MHz on solutions containing enzyme, Mn (II) and glucose at different
concentrations. From these measurements, the normalized paramagnetic contributions
1/fT1 p to the relaxation rates of H α1 , H β1
 and H β2  protons have been obtained by
subtracting the diamagnetic contributions from the total observed relaxation rates
measured in the presence of Mn(II). The normalized relaxation rates, 1/fTl p were
calculated on the assumption that 38 % of glucose is present as α anomer and 62 % as β
anomer (Schray and Benkovic, 1978).
To determine distance r from 1/fTl p rates, using eq. (1), one needs to evaluate
correlation time τC. In addition, it is necessary to establish that the relaxation of the
ligand nucleus in the enzyme is not exchange limited and to know the stoichiometry ‘q’
of the binding of the ligand in enzyme–Mn (II)–ligand complex. τC was evaluated from
the ratio of 1/fTl p at 270 and 500 MHz. Lack of exchange limitation was assumed on
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Figure 3. Relative location of D-glucose (ß-anomer) and the spin label with respect to the
direct binding site of Mn (II). The distance from Mn (II) to the H α1  of glucose is shown in
parentheses.
 
the basis that 1/fTl p values were an order of magnitude lower than 1/fT2 p values
calculated for the anomeric proton (not shown). As only one glucose molecule is known
to bind a molecule of brain hexokinase (Ellison et al., 1974) ‘q’ is equal to one. Eq. (1)
was then used to calculate the distances of various protons of glucose from the tight
binding Mn (II) ion. This is shown schematically in figure 3.
In order to plant another paramagnetic locus on the enzyme for mapping of ligand
binding sites, we have also covalently modified hexokinase with a spin label 3-(2-
iodoacetamido)-2,2,5,5-tetramethyl-l-pyrrolidinyloxyl. DTNB titration of the sul-
phydryl groups of the labelled and unlabelled enzyme indicates that the spin label is
incorporated at a fast reacting sulphydryl residue of the enzyme with a stoichiometry of
one. Enzyme retained full catalytic activity and also the same affinity for Mn (II)
indicating that the spin labelled enzyme had retained its native conformation. The
electron spin resonance spectrum of the labelled enzyme at pH 8·0 indicates that the
label has moderate mobility with a rotational correlation time (τr) of 4·2 ± 2·1 ns which
is much shorter than the τr of the enzyme which is approximately 25 ns. Splitting
between low field minima and the high field maxima remains unaltered indicating easy
accessibility of the label to the solvent. Addition of Mg (II) (500 µΜ) has no effect on
the spectral characteristics of the enzyme-bound spin label. However addition
of Mn (II) produces a reduction in the peak height of the central line without any
appreciable line broadening. Saturation of the spin labelled enzyme with Mn (II)
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quenches the central ESR line by about 23 % (figure 2). Using this maximum reduction
in height of the central ESR line and a value of 2·2 ns for electron spin-lattice relaxation
time of enzyme bound Mn (II) (Jarori et al., 1981), the distance between tight-binding
Mn (II) ion and nitroxyl group on the labelled enzyme has been estimated to be about
21 A (Mehta, 1983,1984). This distance should be considered as approximate since the
spin label is not as rigidly immobilized on the enzyme as required by Leigh’s theory
(Leigh, 1970) used for calculation of the distance.
Figure 3 shows in a schematic way, the location of glucose and spin labelled sites with
respect to tight binding Mn (II) ion.
 
UV difference spectroscopic evidence for more than one binding site for Glc-6-P on the
enzyme and for the existence of an enzyme-glucose-Glc-6-P complex
 
Our UV difference spectroscopic studies have provided us with an additional insight
into the nature of interaction of sugar ligands with brain hexokinase. Figure 4 shows
that the nature of the difference spectrum induced in brain hexokinase by 100 µΜ
Glc-6-P is quite different from that induced by 2·5 mM Glc-6-P. Since the ratio
between the induced difference at any two wavelengths such as 250 nm and 285 nm is
quite different at these two concentrations of Glc-6-P, it follows that Glc-6-P interacts
 
 
 
Figure 4.   Glc-6-P induced difference spectra of brain hexokinase. Difference spectra were
obtained in 10 mM NEM acetate buffer, pH 8·0, containing 5 mM 2-mercaptoethanol;
temperature 22°C; 1 cm light path quartz cell; sample volume, 1 ml; scan rate, 6 nm/min.; band
width,  1 nm.–·–·–, 17·2 µΜ hexokinase and 100 µΜ Glc-6-P; –––––15·7 µΜ hexokinase
and 2·5 mM Glc-6-P;……18·7 µΜ hexokinase and 10 mM glucose were present in both the
cells. 100 µΜ Glc-6-P was added to the sample cell.
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with the enzyme at more than one site as suggested by Lazo et al. (1980) on the basis of
their binding studies.
Though glucose by itself does not cause any change in the UV absorption spectrum
of the enzyme, together with 100 µΜ Glc-6-P it induces a difference spectrum quite
different from the one induced by 100 µΜ Glc-6-P alone (figure 4). This signifies the
formation of an abortive ternary complex, enzyme-glucose-Glc-6-P and indicates
interaction between glucose and Glc-6-P sites on the enzyme, supporting earlier
suggestion that binding of Glc-6-P to the enzyme is glucose dependent (Redkar and
Kenkare, 1975; Ellison et al., 1975; Lazo et al., 1980). Lazo et al (1980) have suggested
that the enzyme has high affinity (KD ≈ 2·5 µΜ) and low affinity (KD ≈ 250 µΜ) sites
for Glc-6-P. if one accepts this suggestion, then it follows that it is the high affinity site
which is modulated by glucose.
 
 
Chromatography of brain hexokinase on a phosphocellulose column: Its significance to the
problem of ligand binding sites
 
In our laboratory, routine purification of brain hexokinase involves as a final step
cellulose phosphate chromatography at pH 7·7 (Swarup, 1979; Swarup and Kenkare,
1980). Since at this pH, the matrix as well as the enzyme are negatively charged,
chromatography of the enzyme on the phosphocellulose column cannot be considered
as ion-exchange chromatography. Rather, since the enzyme can be specifically eluted
with as low a concentration as 13 µΜ Glc-6-P or 2 mM ATP, it is proper to consider it
as affinity chromatography (Swarup, 1979; Mehta, 1984).
During the course of our experiments to investigate the affinity nature of
phosphocellulose chromatography, it became obvious to us that binding of hexokinase
to the phosphocellulose column and its elution there from has a bearing on the problem
of regulatory sites of brain hexokinase that bind phosphate bearing ligands. These
experiments (Mehta, 1984) are briefly discussed below.
Chromatographic behaviour of brain hexokinase on a phosphocellulose column was
investigated using a pure preparation. The columns were routinely equilibrated with
10 mM Tris-HCl buffer, pH 7·7, containing 10 mM glucose, 1 mM EDTA and 5 mM 2-
mercaptoethanol (Buffer A). After loading the enzyme, the column was washed with
two column volumes of the equilibrating buffer. No leakage from the column was
observed. The enzyme failed to bind to the column in the presence of 50 µΜ Glc-6-P or
2 mM Ρi· The bound hexokinase could be eluted from the column using the phosphate
bearing ligands of brain hexokinase. The actual concentrations of the ligands required
for elution was determined by using gradients and are shown in table 2. These ligand
concentrations are low enough to rule out ionic strength as the basis of their eluting
power. On the other hand, these concentrations are generally within an order of
magnitude of their KD values with respect to the enzyme and also approximately
proportional to their KD values. This leads one to conclude that ligands Glc-6-P, ATP,
ADP, AMP and Pi function as affinity eluants in the chromatography of hexokinase on
cellulose phosphate. This conclusion is strengthened by the observation that in the
absence of phosphate-bearing ligands, 200 mM KCl is required for elution of
hexokinase from the phosphocellulose column (table 2).
It soon became clear that the presence of glucose in the regenerating and eluting
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Table 2. Concentration of ligands required for elution of
brain hexokinase from a phosphocellulose column.
 
a Data of Lazo et al. (1980).
b Data of Ellison et al. (1974).
c Data of Redkar and Kenkare (1975).
d Data of Ning et al. (1969).
e KD values for Pi differ widely depending on the method.
 
 
buffers is essential for phosphocellulose to function as affinity matrix When glucose
was omitted from buffer A, Glc-6-P, ATP or Pi could not elute the enzyme effectively
even at concentrations five fold higher than those required when glucose is present in
the regenerating buffer (table 2). One may therefore conclude that glucose induces a
specific phosphate site on the enzyme through which it binds to phosphocellulose. A
corollary to this conclusion is that there is a region on the enzyme to which all the
phosphate bearing ligands of the enzyme bind. It may be argued that these ligands bind
at different sites but elute the enzyme by inducing conformational changes. It is
however difficult to accept this argument, because excepting Glc-6-P, none of the other
ligands have been shown to induce recognizable conformational changes. Also, it is
easier to assume that glucose induces a single site on the enzyme to which all the ligands
bind rather than different sites for different ligands. A common site for all the
phosphate bearing ligands can explain the relief of the Glc-6-P induced inhibition of
the enzyme by ATP and Pi (Colowick, 1973; Purich et al., 1973). If one assumes as
suggested in a previous section that glucose modulates a regulatory site for Glc-6-P on
the enzyme, then the present results can also explain how Pi reverses Glc-6-P induced
inhibition without having any effect on the catalytic activity of the enzyme. It also
explains how Pi stimulates reverse hexokinase reaction though it has no effect on the
reaction in the forward direction (Solheim and Fromm, 1983). The results presented
here perhaps provides a new way of looking at the regulation of brain hexokinase by
suggesting that all the phosphate bearing effector molecules bind at the same site
induced by glucose. 
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